Google to pay $8 million to settle claims of deceptive ads -Texas AG

WASHINGTON (Reuters) -Google, a unit of Alphabet, has agreed to pay $8 million to settle claims it used deceptive advertisements to promote the Pixel 4 smartphone, Texas Attorney General Ken Paxton announced on Friday. The search and advertising giant, which also makes Android smartphone software and owns YouTube, has been scrutinized for antitrust and consumer…

Read More

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

By Blake Brittain WASHINGTON (Reuters) – The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals USA Inc’s challenge to a $235 million award to GlaxoSmithKline LLC in a patent dispute over generic drugs involving a heart medication. The justices turned away Israel-based Teva’s appeal of a lower court’s ruling reinstating the jury award…

Read More

Sarepta surges after FDA panel backs Duchenne gene therapy

By Aditya Samal (Reuters) -Shares of Sarepta Therapeutics jumped 25% on Monday as a backing by the U.S. health regulator’s advisers increased the certainty of an accelerated approval for the company’s gene therapy for a muscle-wasting genetic disorder. The stock was set for its biggest percentage jump in over three years, while the drugmaker’s market…

Read More